This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEE410VN_M.jpgInvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.
Wells Fargo initiated coverage on Amazon.com (NASDAQ:AMZN) with an Overweight rating and a price target of $159.00. Meanwhile, Edgewater Research upgraded the company to Outperform from Market Perform, as InvestingPro reported in real time.
Yesterday, The Wall Street Journal reported that Amazon is planning to launch an ad-supported tier for its Prime Video streaming service. This follows similar moves by competitors like Netflix (NASDAQ:NFLX) and Disney (NYSE:DIS), who are also exploring ad-supported options to support content spending. Additionally, Amazon is reportedly in talks with Warner Bros Discovery (NASDAQ:WBD) and Paramount (NASDAQ:PARA) to add ad-based tiers to their streaming services through Prime Video channels. Amazon, Paramount, and Warner have declined to comment on the matter, the WSJ said.
Wolfe Research upgraded Aptiv (NYSE:APTV) to Outperform from Peerperform with a price target of $130.00.
The firm sees several upcoming catalysts for Aptive, including a strong upward trajectory for margins, and significant potential for upside to consensus estimates. 2023 Street consensus of $4.38 EPS is consistent with the company’s $4.00-$4.50 guidance, but Wolfe expects guidance to be raised on Q2/23 earnings call in August.
Evercore ISI upgraded Marsh & McLennan (NYSE:MMC) to Outperform from In Line and raised its price target to $199.00 from $195.00, expecting a 4-5% upside to consensus EPS with more visibility given a greater ability to leverage Centers of Excellence.
Piper Sandler upgraded Glaukos (NYSE:GKOS) to Overweight from Neutral and raised its price target to $80.00 from $55.00, noting it believes the Street is underestimating the ramp of both iStent Infinite and, more critically, iDose.
Jump on the biggest news for your portfolio amid a barrage of market headlines: Always be the first to know with InvestingPro.
Start your free 7-day trial now.
